ASH 2013: constant progress: not only for B-cell neoplasms Michael Steurer editorial 16 September 2014 Pages: 123 - 124
The challenge of soft tissue sarcomas—critical aspects of therapies with curative intent Georg Pall editorial 20 August 2014 Pages: 125 - 125
Highlights of the American Society of Hematology Meeting 2013: hemostaseology Clemens FeistritzerSophie Maria Wildner short review 15 July 2014 Pages: 126 - 129
Aggressive lymphoma at ASH 2013: R-CHOP under attack? Thomas Nösslinger short review 24 June 2014 Pages: 130 - 133
ASH 2013: short review on myeloproliferative neoplasms Stefan Schmidt short review 11 September 2014 Pages: 138 - 140
ASH Update 2013: chronic lymphocytic leukemia and indolent lymphoma Michael Steurer short review 09 September 2014 Pages: 141 - 143
Molecular monitoring of minimal residual disease in acute leukemia Otto ZachJohannes Clausen short review 10 September 2014 Pages: 144 - 147
Venous thromboembolism in children with acute lymphoblastic leukemia Jolanta Skalska-SadowskaKatarzyna Derwich short review 20 August 2014 Pages: 148 - 151
The role of maintenance strategies in breast cancer Elisabetta MunzoneMarco Colleoni short review 05 August 2014 Pages: 152 - 156
Clinicopathological profile of bilateral breast cancer at a tertiary cancer center in South India K. C. LakshmaiahUmesh DasM. Vijayakumar original report 11 July 2014 Pages: 157 - 161
Challenges with overall survival as an endpoint for efficacy assessment in first line metastatic breast cancer randomized controlled clinical trials and the investigation of truncated overall survival as an alternative endpoint Colin NeateAlexander StrasakLee Kaiser special report 20 August 2014 Pages: 162 - 168
Neoadjuvant chemotherapy for soft tissue sarcoma Ewald Wöll short review 05 September 2014 Pages: 169 - 171
Importance of intraoperative radiation therapy in the treatment of soft tissue sarcoma: data at hand Arpad Sztankay review 30 July 2014 Pages: 172 - 176
Surgical aspects in the treatment of retroperitoneal soft tissue sarcomas Alexander PerathonerReinhold Kafka-RitschMatthias Zitt short review 11 July 2014 Pages: 177 - 180
Long-term tolerability of the BRAF inhibitor vemurafenib in patients with metastatic melanoma: current study data and real-life observations Cathrin BalmelliMichael MarkAndreas Wicki special report 15 July 2014 Pages: 181 - 186
Colorectal cancer: screening and some notes on the prevention Paul BergmeisterAlois Hermann Lang short review 09 July 2014 Pages: 187 - 191